Bachem Holding, an innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides, has raised CHF 583.5 million through an accelerated bookbuilding process by issuing 750,000 new shares at a placement price of CHF 778 per
Tags :Nadia Tarolli
Novaremed, a privately held clinical-stage biopharmaceutical company, expands its pipeline of non-opioid treatment candidates for chronic pain indications through the acquisition of Metys Pharmaceuticals. The acquisition broadens Novaremed’s existing pipeline by adding both
EnBiotix, a Boston-based biotech company focused on rare diseases, is merging with Swiss oncology and antimicrobial resistance-focused company Polyphor. A merger agreement under which Polyphor will use all of EnBiotix’s outstanding share capital in
Vischer advised the sellers of Mestex AG on all legal issues related to the sale of their shares and stock options to the pharmaceutical company Grünenthal, a global operator in pain management and related
The team was led by Matthias Staehelin (pictured) and Moritz Jäggy with Sebastian Flückiger and Pauline Pfirter (all Corporate). Partners David Rosenthal (Data Privacy) and Nadia Tarolli (Tax) assisted as well.
Walder Wyss advises Boehringer Ingelheim. The team was led by Alexander Gutmans (Partner, Corporate/M&A and Venture Capital - pictured left) and Robert von Rosen (Partner, Corporate/M&A and Venture Capital). VISCHER advised
VISCHER is advising Noema Pharma in this transaction. The team is led by Matthias Staehelin (Corporate, pictured left). Walder Wyss advised Gilde Healthcare Partners, Polaris Partners, Invus Capital and BioMedInvest as investors. The team included
The team included Matthias Staehelin (Partner, Corporate - pictured), Sebastian Flückiger (Associate, Corporate), Nadia Tarolli (Partner, Tax) and Adrian Briner (Senior Associate, Tax).
VISCHER advised Polyphor on all legal issues in connection with the transaction. The team was led by Christian Wyss (pictured) with Matthias Staehelin, Fiona Gao, Camill Oberhausser (all Corporate) and Nadia Tarolli (Tax).
The team included Matthias Staehelin (pictured), Angelo Imperiale and Sebastian Flückiger (all Corporate) as well as Nadia Tarolli and Adrian Briner (both Tax).